Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Joshua Labrin, MD

News

New Oral Anticoagulants Safe and Effective for Atrial Fibrillation Treatment

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: Is there a difference in efficacy and safety among new oral anticoagulants compared to warfarin in subgroups of patients with...

  • Read More

News

Sepsis Diagnoses Are Common in ED, but Many Septic Patients in the ED Do Not Receive Antibiotics

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: Has the frequency of sepsis rates, along with administration of antibiotics in U.S.

  • Read More

News

Multifaceted Discharge Interventions Reduce Rates of Pediatric Readmission and Post-Hospital ED Utilization

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: Do interventions at discharge reduce the rate of readmissions and post-hospitalization ED visits among pediatric patients?...

  • Read More

News

Warfarin Initiation in Atrial Fibrillation Associated with Increased Short-Term Risk of Stroke

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: Is the initiation of warfarin associated with an increased risk of ischemic stroke in patients with atrial fibrillation (Afib...

  • Read More

News

Comorbidities Contribute to Potentially Avoidable Hospital Readmissions

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: What is the role of comorbidities in 30-day potentially avoidable readmissions? Background: Higher comorbidity burden has been...

  • Read More

News

Uncomplicated Skin Infections in Ambulatory Setting Commonly Involve Avoidable Antibiotic Exposure

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: What are the current prescribing practices for antibiotics used to treat skin and soft tissue infections in the outpatient...

  • Read More

News

Resident Handoff Bundle Reduces Medical Errors and Adverse Events, Improves Handoff Quality

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: In a pediatric inpatient setting, is the use of a handoff program associated with improved patient safety measures and handoff...

  • Read More

News

Modified IV Acetylcysteine Infusion Reduces Adverse Effects

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: Does a shorter regimen of IV acetylcysteine reduce adverse effects compared to the standard regimen? Background: Acetaminophen...

  • Read More

News

No Mortality Benefit with Treatment of Single Peripheral Pulmonary Emboli

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: Does treatment of single peripheral pulmonary emboli impact mortality and rates of post-discharge venous thromboembolism (VTE...

  • Read More

News

Healthcare-Associated Infections Continue to Impact the U.S. Healthcare System Financially

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Clinical question: What is the estimated cost of healthcare-associated infections (HAI) to the U.S. healthcare system? Background: In spite of...

  • Read More

News

Hospitalist Reviews on Healthcare-associated Infections, Mortality Benefit with Single Peripheral Pulmonary Emboli, Oral Anticoagulants to Treat Atrial Fibrillation

Author:
Allison L. Smith, MD
Laine J. Murphey, MD, PhD
Olamide Zaka, MD
Joshua Labrin, MD
Kelly L. Sopko, MD, FHM
Kelly C. Sponsler, MD, FHM

Also reviewed this month: comorbidities and avoidable hospital readmissions, effect of resident handoff bundles on medical errors, pediatric...

  • Read More

News

In the Literature: Research You Need to Know

Author:
Emily Tarvin, MD
Kevin Flemmons, MD, SFHM
Laine J. Murphey, MD, PhD
J. Daniel Markley, DO
Joshua Labrin, MD
Kelly C. Sponsler, MD, FHM
Section OF

Revised GOLD guidelines describe updated approach to COPD diagnosis, management

  • Read More

News

ITL: Physician Reviews of HM-Relevant Research

Author:
Emily Tarvin, MD
Kevin Flemmons, MD, SFHM
Laine J. Murphey Md, PhD
J. Daniel Markley, DO
Joshua Labrin, MD
Kelly C. Sponsler, MD, FHM
Section OF

Systematic review highlights several interventions that improve discharge handovers; Longer duration of in-hospital cardiac resuscitation...

  • Read More

News

In the Literature: Research You Need to Know

Author:
Kelly Cunningham Sponsler, MD
Neesha Choma, MD, MPH
Kelly Sopko, MD
Joshua Labrin, MD
Angela Horton, MD
Allison Smith, MD
Shelley Ellis, MD, MPH
Section OF

Suboptimal Quality of Life and Burnout are Common in Internal-Medicine Residents

  • Read More

News

What Is the Appropriate Use of Antibiotics In Acute Exacerbations of COPD?

Author:
Kelly Cunningham Sponsler, MD
J. Daniel Markley, DO
Joshua Labrin, MD

Antibiotics are not recommended as empiric therapy for all patients with AECOPD

  • Read More

Pages

  • 1
  • 2
  • last ยป
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close